483 Bell Pharmaceuticals Nov 2015

483 Bell Pharmaceuticals Nov 2015

Shalonda Clifford FDA, Courtney Tiegs FDA$119.00 - Available Now

FDA investigators audited the Bell Pharmaceuticals - Belle Plaine, MN, United States facility and issued 4 inspectional observations (via FDA 483) on 20 Nov 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 20 Nov 2015
  • Location: Belle Plaine, United States
  • FEI: 2123499
Add To Cart